LWMI
GILD icon

Legacy Wealth Management (Idaho)’s Gilead Sciences GILD Stock Holding History

Legacy Wealth Management (Idaho)’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-159
Closed -$22.2K – 489
2026
Q1 		$22.2K Buy
159
+84
+112% +$11.8K 0.01% 367
2025
Q4 		$9.21K Buy
75
+28
+60% +$3.4K ﹤0.01% 438
2025
Q3 		$5.22K Hold
47
– – ﹤0.01% 430
2025
Q2 		$5.21K Hold
47
– – ﹤0.01% 394
2025
Q1 		$5.27K Hold
47
– – ﹤0.01% 418
2024
Q4 		$4.51K Hold
47
– – ﹤0.01% 400
2024
Q3 		$4.35K Buy
+47
New +$3.59K ﹤0.01% 401

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Legacy Wealth Management (Idaho)'s GILD Position: Q2 2026 in Review

Legacy Wealth Management (Idaho) sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 159 shares — an estimated $22.2K sold.

Legacy Wealth Management (Idaho) first reported a position in GILD in Q3 2024 and held it in 7 quarters. The position peaked at $22.2K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Legacy Wealth Management (Idaho) reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Legacy Wealth Management (Idaho) sold 159 Gilead Sciences shares in Q2 2026, an estimated $22.2K.
  • Legacy Wealth Management (Idaho) first reported a position in Gilead Sciences in Q3 2024 and held it in 7 quarters.
  • Legacy Wealth Management (Idaho)'s Gilead Sciences position peaked at $22.2K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Legacy Wealth Management (Idaho)'s 13F filing for Q2 2026, filed 13 Aug 2026.